This Signals a Transformational Leap Forward for the Company and the Future of Diagnostic Medicine IRVINE, Calif., Jan. 12, 2026 /PRNewswire-PRWeb/ -- EmeritusDX, one of the nation's fastest growing leaders in cancer diagnostics molecular testing hematopathology and precision medicine,...
↧